Drawing for NOVOTECH

USPTO serial 79221025

NOVOTECH

Reviewed by CopyMark Law Group

Reg. 5629966Status 739Registered
Filing date
Status date
Registration date
Dec 18, 2018
Examiner
PAPALE, LISA ANNE
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with NOVOTECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew P. Hintz, Esq.

Matthew P. Hintz, Esq. Lowenstein Sandler LLPOne Lowenstein DriveRoseland, NJ 07068United States

Goods and services

ClassDescriptionStatusFirst use
042Medical and scientific research, namely, conducting clinical trials for others; conducting and managing clinical trials in the fields of pharmaceuticals, biotechnology and other related industries; conducting clinical trials for others in the nature of scientific research; providing information about the results of clinical trials in the fields of pharmaceuticals and biotechnology; scientific research; medical research in the nature of scientific research for medical purposes; preparation of statistics reports for scientific research; preparation of biostatistics reports for scientific research in the fields of pharmaceuticals, biotechnology and other related industries; provision of information and data relating to medical and scientific research for pharmaceuticals, biotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research services, namely, medical monitoring services for research in the fields of pharmaceuticals, biotechnology and other related industries; quality audits, namely, quality evaluation services for the pharmaceuticals industry; preparation of reports and applications to regulators relating to aspects of clinical trials; provision of information and data to scientists, manufacturers and health authorities relating to pharmaceutical and biotechnology quality standards; technical writing of clinical report forms which are required by clinical trial drug protocolsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 24, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jun 24, 2025C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jun 16, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 25, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Nov 25, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 25, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 25, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 25, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 25, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 18, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 17, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 14, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 12, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 23, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 23, 2019FIMPFINAL DISPOSITION PROCESSED—
Mar 18, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 18, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 2, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 2, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 29, 2018GPNXNOTIFICATION PROCESSED BY IB—
Sep 12, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 12, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 12, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 27, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 27, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 27, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 27, 2018ALIEASSIGNED TO LIE—
Jun 21, 2018LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jun 8, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 8, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 1, 2018LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 29, 2017RFNTREFUSAL PROCESSED BY IB—
Dec 11, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 11, 2017RFRRREFUSAL PROCESSED BY MPU—
Nov 28, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 28, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 27, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 22, 2017DOCKASSIGNED TO EXAMINER—
Nov 22, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 16, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance